Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
26135 | 262 | 27.6 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
147 | 2 | SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//LIPOSOMES | 23275 |
26135 | 1 | LYMPHATIC TARGETING//ACTIVATED CARBON PARTICLES//BIOMED ENGN CANC | 262 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LYMPHATIC TARGETING | authKW | 671298 | 5% | 48% | 12 |
2 | ACTIVATED CARBON PARTICLES | authKW | 349635 | 2% | 50% | 6 |
3 | BIOMED ENGN CANC | address | 266390 | 2% | 57% | 4 |
4 | LYMPHATIC DRUG DELIVERY | authKW | 262229 | 1% | 75% | 3 |
5 | ACTIVE CARBON NANOPARTICLES | authKW | 233094 | 1% | 100% | 2 |
6 | ENDOLYMPHATIC INJECTIONS | authKW | 233094 | 1% | 100% | 2 |
7 | INTRALYMPHATIC CHEMOTHERAPY | authKW | 233094 | 1% | 100% | 2 |
8 | NANO MICROBUBBLES | authKW | 233094 | 1% | 100% | 2 |
9 | LYMPH NODE TARGETING | authKW | 209782 | 1% | 60% | 3 |
10 | DRUG DELIVERY DISPOSIT DYNAM GRP | address | 155395 | 1% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1274 | 41% | 0% | 108 |
2 | Oncology | 544 | 25% | 0% | 65 |
3 | Chemistry, Medicinal | 100 | 6% | 0% | 17 |
4 | Physiology | 78 | 7% | 0% | 18 |
5 | Chemistry, Multidisciplinary | 70 | 13% | 0% | 35 |
6 | Immunology | 69 | 10% | 0% | 25 |
7 | Materials Science, Biomaterials | 40 | 2% | 0% | 6 |
8 | Biophysics | 30 | 5% | 0% | 13 |
9 | Medicine, Research & Experimental | 27 | 5% | 0% | 13 |
10 | Nanoscience & Nanotechnology | 24 | 4% | 0% | 11 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOMED ENGN CANC | 266390 | 2% | 57% | 4 |
2 | DRUG DELIVERY DISPOSIT DYNAM GRP | 155395 | 1% | 67% | 2 |
3 | ACRF RATIONAL DRUG DISCOVERY BIOTA STRUCT B | 116547 | 0% | 100% | 1 |
4 | BIOMED ENGN CANC BIOMED ENGN CANC | 116547 | 0% | 100% | 1 |
5 | CELL CYCLE ONCOL GRP | 116547 | 0% | 100% | 1 |
6 | CELL CYCLE ONCOL GRP CICLON | 116547 | 0% | 100% | 1 |
7 | CLIN GEN SURG SURG ONCOL THORAC SURG | 116547 | 0% | 100% | 1 |
8 | DONGHU EXP STN LAKE ECOSYST | 116547 | 0% | 100% | 1 |
9 | GLANDS SURG 3 | 116547 | 0% | 100% | 1 |
10 | HEATH SANTIAGO DE COMPOSTELA IDIS | 116547 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYMPHOLOGY | 35322 | 7% | 2% | 18 |
2 | ANTI-CANCER DRUG DESIGN | 6680 | 2% | 1% | 6 |
3 | ANTI-CANCER DRUGS | 3561 | 4% | 0% | 10 |
4 | EKSPERIMENTALNAYA ONKOLOGIYA | 2347 | 2% | 0% | 5 |
5 | JOURNAL OF MICROENCAPSULATION | 1617 | 2% | 0% | 5 |
6 | ADVANCED DRUG DELIVERY REVIEWS | 1561 | 2% | 0% | 6 |
7 | JOURNAL OF CONTROLLED RELEASE | 1555 | 4% | 0% | 10 |
8 | INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1426 | 5% | 0% | 14 |
9 | JOURNAL OF DRUG TARGETING | 1193 | 2% | 0% | 4 |
10 | PHARMACEUTICAL RESEARCH | 1169 | 3% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ABELLAN-POSE, R , CSABA, N , ALONSO, MJ , (2016) LYMPHATIC TARGETING OF NANOSYSTEMS FOR ANTICANCER DRUG THERAPY.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 9. P. 1194 -1209 | 42 | 27% | 1 |
2 | MOGH, SM , MOGHIMI, M , (2008) ENHANCED LYMPH NODE RETENTION OF SUBCUTANEOUSLY INJECTED IGG1-PEG(2000)-LIPOSOMES THROUGH PENTAMERIC IGM ANTIBODY-MEDIATED VESICULAR AGGREGATION.BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. VOL. 1778. ISSUE 1. P. 51 -55 | 13 | 87% | 10 |
3 | NISHIOKA, Y , YOSHINO, H , (2001) LYMPHATIC TARGETING WITH NANOPARTICULATE SYSTEM.ADVANCED DRUG DELIVERY REVIEWS. VOL. 47. ISSUE 1. P. 55 -64 | 18 | 62% | 113 |
4 | ABELLAN-POSE, R , RODRIGUEZ-EVORA, M , VICENTE, S , CSABA, N , EVORA, C , ALONSO, MJ , DELGADO, A , (2017) BIODISTRIBUTION OF RADIOLABELED POLYGLUTAMIC ACID AND PEG-POLYGLUTAMIC ACID NANOCAPSULES.EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. VOL. 112. ISSUE . P. 155 -163 | 16 | 50% | 0 |
5 | CUONG, NV , HSIEH, MF , (2011) MOLECULAR TARGETING OF LIPOSOMAL NANO-PARTICLES TO LYMPHATIC SYSTEM.CURRENT CANCER DRUG TARGETS. VOL. 11. ISSUE 2. P. 147 -155 | 22 | 37% | 14 |
6 | RYAN, GM , KAMINSKAS, LM , PORTER, CJH , (2014) NANO-CHEMOTHERAPEUTICS: MAXIMISING LYMPHATIC DRUG EXPOSURE TO IMPROVE THE TREATMENT OF LYMPH-METASTATIC CANCERS.JOURNAL OF CONTROLLED RELEASE. VOL. 193. ISSUE . P. 241 -256 | 33 | 19% | 12 |
7 | OUSSOREN, C , STORM, G , (2001) LIPOSOMES TO TARGET THE LYMPHATICS BY SUBCUTANEOUS ADMINISTRATION.ADVANCED DRUG DELIVERY REVIEWS. VOL. 50. ISSUE 1-2. P. 143-156 | 20 | 36% | 169 |
8 | BORRAJO, E , ABELLAN-POSE, R , SOTO, A , GARCIA-FUENTES, M , CSABA, N , ALONSO, MJ , VIDAL, A , (2016) DOCETAXEL-LOADED POLYGLUTAMIC ACID-PEG NANOCAPSULES FOR THE TREATMENT OF METASTATIC CANCER.JOURNAL OF CONTROLLED RELEASE. VOL. 238. ISSUE . P. 263 -271 | 16 | 37% | 0 |
9 | XIE, YM , TANG, XH , HE, J , CHENG, M , ZHENG, KB , ZHANG, Y , (2006) PREPARATION OF CARBON NANOPARTICLE SUSPENSION WITH EXCELLENT LYMPHATIC TRACING PROPERTIES.NEW CARBON MATERIALS. VOL. 21. ISSUE 3. P. 259-262 | 9 | 75% | 1 |
10 | SINGH, I , SWAMI, R , KHAN, W , SISTLA, R , (2014) LYMPHATIC SYSTEM: A PROSPECTIVE AREA FOR ADVANCED TARGETING OF PARTICULATE DRUG CARRIERS.EXPERT OPINION ON DRUG DELIVERY. VOL. 11. ISSUE 2. P. 211 -229 | 23 | 19% | 16 |
Classes with closest relation at Level 1 |